Frédéric Sottilini, CEO of Carthera
Vygon signs exclusive agreement with Carmat to develop and manufacture vascular graft compatible with Aeson artificial heart
© Vygon
CardioRenal receives FDA Breakthrough Device Designation for TENOR
© CardioRenal
Carthera: promising results from SonoCloud-9 clinical trial published in Lancet Oncology
Ciliatech raises €3.5M in Series A funding
© Studio CAP PHOTO